ATPase-regulated autophagosome biogenesis.

Aggrephagy Atpase autophagosome micronucleophagy mitophagy omegasome

Journal

Autophagy
ISSN: 1554-8635
Titre abrégé: Autophagy
Pays: United States
ID NLM: 101265188

Informations de publication

Date de publication:
18 Sep 2023
Historique:
medline: 19 9 2023
pubmed: 19 9 2023
entrez: 18 9 2023
Statut: aheadofprint

Résumé

Omega-shaped domains of the endoplasmic reticulum, known as omegasomes, have been suggested to contribute to autophagosome biogenesis, although their exact function is not known. Omegasomes are characterized by the presence of the double FYVE domain containing protein ZFYVE1/DFCP1, but it has remained a paradox that depletion of ZFYVE1 does not prevent bulk macroautophagy/autophagy. We recently showed that ZFYVE1 contains an N-terminal ATPase domain which dimerizes upon ATP binding. Mutations in the ATPase domain that inhibit ATP binding or hydrolysis do not prevent omegasome expansion and maturation. However, omegasome constriction is inhibited by these mutations, which results in an increased lifetime and thereby higher number of omegasomes. Interestingly, whereas

Identifiants

pubmed: 37722386
doi: 10.1080/15548627.2023.2255967
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-2

Auteurs

Viola Nähse (V)

Centre for Cancer Cell Reprogramming, Faculty of Medicine, University of Oslo, montebello, Oslo Norway.
Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Montebello, Oslo, Norway.
Department of Anatomy and Stem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

Kay O Schink (KO)

Centre for Cancer Cell Reprogramming, Faculty of Medicine, University of Oslo, montebello, Oslo Norway.
Department of Molecular Medicine, Institute of Basic MedicalSciences, University of Oslo, Oslo, Norway.

Harald Stenmark (H)

Centre for Cancer Cell Reprogramming, Faculty of Medicine, University of Oslo, montebello, Oslo Norway.
Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Montebello, Oslo, Norway.

Classifications MeSH